Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISA101/ISA101b Vaccine in Advanced HPV16+ Cervical Cancer
NCT02128126Phase 2Completed
- Sponsor
- ISA Pharmaceuticals
- Start
- Sep 2013
- Primary completion
- Aug 2018
- Modality
- Peptides, Peptide-based Cancer Vaccines
- Countries
- 3
01
Overview
A Phase 2 trial of SLP-HPV-01 in Cervical Cancer (CC), sponsored by ISA Pharmaceuticals. Started Sep 2013; status: completed.
02
Drugs
SLP-HPV-01
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT02128126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02128126.